Jordan Julie 4

4 · Neurogene Inc. · Filed Feb 24, 2026

Form 4

Period: 2026-02-20

Chief Medical Officer

Transactions

Award
Common Stock
[F1][F2]
2026-02-20+4,900→ 13,300 total
Award
Stock Option (Right to Buy)
[F3]
2026-02-20+29,600→ 29,600 total
Exercise: $17.64Exp: 2036-02-20→ Common Stock (29,600 underlying)

Footnotes (3)

[F1]Consist of 4,900 restricted stock units, which will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued provision of services to the Issuer on each vesting date.
[F2]Consist of (a) 8,400 restricted stock units granted on March 26, 2025, which will vest annually in equal installments on March 26, 2026, March 26, 2027 and March 26, 2028; and (b) 4,900 restricted stock units granted on February 20, 2026, which will vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029, in each case subject to the Reporting Person's continued provision of services to the Issuer on each vesting date.
[F3]This option represents the right to purchase 29,600 shares of the Issuer's common stock, one quarter of which will vest on the first anniversary of the grant date with the remaining three quarters vesting in equal monthly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.

Signature

/s/ Donna M. Cochener, as attorney-in-fact for Julie Jordan|2026-02-24

Documents

2 files